Abstract
In 2006, the US market for varicose vein treatment devices was valued at
nearly $105 million.
This market consists of endovenous laser ablation, endovenous radio frequency
ablation, surgical stripping, phlebectomy, and sclerotherapy procedures for
varicose veins